MultiCell Technologies Competitors and Similar CompaniesClear all
MultiCell Technologies's competitors and similar companies include Alexion Pharmaceuticals and UNITY Biotechnology.
 MultiCell Technologies MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | ||
Founding Date | Founding Date 1962 | Founding Date 1992 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Woonsocket, US HQ | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations South San Francisco, US HQ |
Employees | Employees 2 | Employees 10,6006% increase | Employees 98 |
Valuation ($) | Valuation ($) 1 m | Valuation ($) 40.3 b | Valuation ($) 23.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $49.3k (FY, 2014) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) N/A |
Net income | Net income ($528.8k) (FY, 2014) | Net income $603.4m (FY, 2020) | Net income ($26m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company
UNITY Biotechnology
HQ
South San Francisco, US
Employees
98
Unity Biotechnology designs therapeutics that prevent various diseases of aging.
View company